MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy.

Stem Cell Res Ther · 2025 · PMC11792327 · PMID 39901236

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

1 N), indicating that this study may capture the early stages of EMT improvement by DSS-Exo and Exo, when the role of inflammatory cytokines is not yet significant (Fig. 1 K).

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.